Volume 5, supplement 1, Supplement, May 2003
Treatment of Epilepsy: Focus on Levetiracetam
Meeting the challenge of treating epilepsy
(p.7-8)
David Chadwick, Peter Wolf
Free Access
Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam
(p.9-16)
Henrik Klitgaard, Asla Pitkänen
Free Access
The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?
(p.17-26)
Emilio Perucca, Svein I. Johannessen
Free Access
Long‐term experience with levetiracetam
(p.33-7)
Bassel Abou‐Khalil, Barry Lazenby
Free Access
Levetiracetam: preliminary efficacy in generalized seizures
(p.39-44)
Dorothée G.A. Kasteleijn‐Nolst Trenité, Edouard Hirsch
Free Access
Preliminary efficacy of levetiracetam in children
(p.45-50)
Tracy A. Glauser, Olivier Dulac
Free Access
Preliminary efficacy of levetiracetam in monotherapy
(p.51-5)
Elinor Ben‐Menachem
Free Access
Safety profile of levetiracetam
(p.57-63)
Santiago Arroyo, Pamela Crawford
Free Access
Role of levetiracetam in the treatment of epilepsy
(p.65-72)
Martin J. Brodie, Jacqueline A. French
Free Access
Treatment of Epilepsy : Focus on Levetiracetam
Efficacy of levetiracetam in partial seizures
(p.27-31)
Orrin Devinsky, Christian Elger
Free Access